Cite
HARVARD Citation
Thiruthaneeswaran, N. et al. (n.d.). OC-1031: The radiosensitivity index predicts benefit from HDR brachytherapy in high-risk prostate cancer. Radiotherapy and oncology. pp. S1086-S1087. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Thiruthaneeswaran, N. et al. (n.d.). OC-1031: The radiosensitivity index predicts benefit from HDR brachytherapy in high-risk prostate cancer. Radiotherapy and oncology. pp. S1086-S1087. [Online].